General Motors
BP
Ford Motor Company
AstraZeneca
DaimlerChrysler
CNN
General Electric
US Senate
Credit Suisse First Boston
Volkswagen
Siemens
Philip Morris
Bloomberg
US State Department
Verizon
AT&T
FIAT
Nestle
HP
General Dynamics
Hewlett Packard
3
ABN Amro
UBS Warburg
Merrill Lynch
New York Stock Exchange
The Economist
France Telecom
Boeing
T-Mobile
Lafarge
AstraZeneca
Safeway
People's Republic of China's
Nestle
Nestle
Sun Microsystems
AstraZeneca
Ministry of Agriculture
Nordea
Tesco
Pfizer
Philips
Lloyds
New York Life Insurance
The Coca Cola Company
Sybase
Sprint
Britvic Softdrinks
Siemens
New York Life Insurance
Canon USA
Nestle
Novell
Ericsson
Lloyds
EDS
BBC
Philip Morris International
Royal & SunAlliance
3
Novartis
Credit Lyonnais
Sun Microsystems
AT&T
British American Tobacco
Norsk Hydro
AstraZeneca
Skanska
BAE Systems
Kodak
Macmillan Publishing
The Royal Mail Group
Henkel
UK Department of Trade & Industry
Bank of Montreal
Danske Bank
BMW
AstraZeneca
Kronos Corporation
US Department of Commerce
Fujitsu Technology Services
Zurich Financial Services
BP
UK Department of Trade & Industry
Ericsson
Philips
Halliburton
BBC
Blue Cross/Blue Shield of Massachusetts
Ericsson
Royal & SunAlliance
T-Mobile
Channel 4 Corporation
Siemens
VHA
Burges Salmon
Motorola
British Telecom
US State Department
Philips
Lloyds
Ferrari
Deloitte & Touche
PA Consulting
Ingersoll-Rand
BBC
US Army
UK Department of Trade & Industry
Henkel
EMC Corporation
US Department of Commerce
Encana Corporation
IEEE
Hewitt Associates LLC
HEALTHvision
Paramount
BP
Lexmark
US Department of Defense
JD Edwards
Sun Microsystems
Philips
Ingersoll-Rand
3
PricewaterhouseCoopers
Pfizer
Vodafone Omnitel
Nomura
US State Department
The McGraw-Hill Companies
Reed Elsevier
Dow Chemical Company
US Department of Defense
Siemens Power Generation
Texas Instruments
General Motors
Forrester Research
McData
Wall Street Journal
Lloyds
US Department of Defense
NASA
SCA
Reuters
ITN
IBM NICA
Forbes.com
General Motors
Nissan North America, Inc.
Hewlett Packard
Toyota Motor
Sun Microsystems
AstraZeneca
The McGraw-Hill Companies
Fox Sports
Society of Petroleum Engineers
US Department of Energy
European Commission
Telecom Italia
General Electric
Harrah's
AXA
General Motors
Sybase
Napster
Oracle
Compuware
Olympus
ABN Amro
ARM
Taylor & Francis
Federal Express
Nissan Motor
MOL
3
Milward Brown Precis
Federal Government of Canada
AstraZeneca
UK Home Office
HM Revenue & Customs
AT&T
3
Hewlett Packard
Vodafone Omnitel
Harvard Business School
Britvic Softdrinks
MOL
Macmillan Publishing
Allianz Life Insurance Co
Nestle
Swiss Army
AstraZeneca
Parliament of Singapore
Philips
VMS
Singapore Police Force
Sony Music
GSA Advantage!
Kaiser Permanente
Stanford Business School
BP
Johns Hopkins
Wachovia
HM Revenue & Customs
General Motors
Standard Life Insurance
Raytheon
Commerzbank
Allstate Insurance
State of Washington
Napa Valley County
3
US State Department
Texas Department of Transportation
American HomePatient
TIBCO
Danske Bank
Sharper Image
Xerox
America Online
3
Lockheed Northrop Grumman
Credit Lyonnais
Dow Chemical Company
Draeger Medical
Swiss Army
Sutter Health
Kenyan AIDS Clinic
University of Washington
State of Minnesota
World Wildlife Fund
Autonomy Group Customers
 
Legal
Autonomy Communications
To unsubscribe from all Autonomy Group e-mail communications, simply send an e-mail to unsubscribe@autonomy.com. This will be processed automatically, you do not need to write anything in the message body.

Legal Disclaimer

Some of the information on this Web Site may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We refer you to the Company's annual reports as well as the Company's most recent prospectus on file with the United Kingdom Listing Authority. These documents contain and identify important factors that could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, dependence on core technology; limited operating history; fluctuations in quarterly results; dependence on new product development; rapid technological and market change; reliance on sales by others; management of growth; dependence on key personnel; rapid expansion; technology risks; volatility of stock price; growth of the Internet; financial risk management; and future growth subject to risks.

Copyright © 2009 Autonomy Corporation plc and its affiliates. All rights reserved. Other trademarks are registered trademarks and the properties of their respective owners.

テクノロジー
機能
製品
ソリューション
サービス
導入実績
パートナーとOEM
ニュース & イベント
企業情報